ArticleFrontiers in cardiovascular medicine2021

Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy.

Yong-Wei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.